Adastra Holdings (XTXXF, $0.03) was a top loser over the last three months, falling -8 to $0.03 per share. A.I.dvisor analyzed 244 stocks in the Pharmaceuticals: Other Industry for the 3-month period ending September 24, 2024, and found that of them (5) exhibited an Uptrend while of them (4) demonstrated a Downtrend. 286 similar cases when XTXXF's price dropped within three months. In out of those 286 cases, XTXXF's price went down during the following month. Based on these historical data, the odds of a Downtrend continuation for XTXXF are